ReviewCureus2023

Effectiveness and Safety of Pembrolizumab in Recurrent and Relapsed Classic Hodgkin Lymphoma: A Systematic Review.

Md Fahad Hossain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.